Oral pathology and oral medicine in Latin American countries: current stage
ÉG. Santos-Leite(Universidad Nacional de Colombia), Ricardo Martínez-Pedraza(Universidad Autónoma de Nuevo León), Wilfredo Alejandro González‐Arriagada(Universidad de Los Andes, Chile), Wilson Delgado‐Azañero(Universidad Peruana Cayetano Heredia), Lays Martin Sobral(Universidade Estadual de Montes Claros), C. Gonzalez de Vega(Universidad Nacional de Colombia), R. Villarroel-Dorrego(Central University of Venezuela), JL. Flores-Ramos(Universidad Mayor de San Andrés), P. Reiván-Ortiz(Viña del Mar University), Md. González-Galván(Universidade Estadual de Campinas (UNICAMP)), Ronell Bologna‐Molina(Universidad de la República de Uruguay), Gerardo Gilligan(Universidad Nacional de Córdoba)
Cited by 10
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58